Retinol binding protein 4, obesity, and insulin resistance in adolescents
Background Obesity is a global problem. Even in poor and developing countries, obesity has reached alarming levels. In childhood, obesity may lead to insulin resistance. Retinol binding protein (RBP4), secreted primarily by liver and adipose tissues, was recently proposed as a link between obesity and insulin resistance. The role of RBP4 in pediatric obesity and its relationship with insulin resistance have not been well elucidated.
Objective To compare RBP4 levels in obese and lean adolescents and to assess for a relationship between RBP4 levels and insulin resistance.
Method This cross-sectional study was conducted in three senior high schools in Padang, West Sumatera, Indonesia. Subjects were adolescents aged 14-18 years, who were obese or normal weight (n=56). We measured subjectsâ€™ body mass index (BMI) and serum RBP4 concentrations. Insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR) index.
Results Similar RBP4 levels were found in the obese and normoweight groups (P>0.05). Higher RBP4 levels were found in the insulin resistant compared to the non-insulin resistant group, but the difference was not significant (P > 0.05).
Conclusion There is no significant difference in mean RBP4 levels in obese adolescents compared to normoweight adolescents. Nor are mean RBP4 levels significantly different between obese adolescents with and without insulin resistance.ÂÂ
WHO Global Strategy on Diet, Physical Activity & Health. Childhood overweight and obesity. 2013. [cited 2014, September 12]. Available from: http://www.who.int/dietphysicalactivity/childhood/en/.
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics. 2012 Update. Circulation. 2012;125:e2-220. https://doi.org/10.1161/CIR.0b013e31823ac046
Lailani D, Hakimi. Pertumbuhan fisik anak obesitas. Sari Pediatri. 2003;5:99-102. https://doi.org/10.14238/sp5.3.2003.99-102
Aycan Z. Obesity in childhood: definition and epidemiology. J Clin Res Ped Endo. 2009;1:44-53. https://doi.org/10.4008/jcrpe.v1i1.25
Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes. 2012;36:1-11. https://doi.org/10.1038/ijo.2011.186
Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360:473-82. https://doi.org/10.1016/S0140-6736(02)09678-2
Choi SH, Hong ES, Lim S. Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol. 2013;4:97. https://doi.org/10.3389/fendo.2013.00097
Kotnik P, Fischer-Posovsky P, Wabitsch M. RBP4: a controversial adipokine. Eur J Endocrinol. 2011;165:703-11. https://doi.org/10.1530/EJE-11-0431
Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents. Pediatrics 2005;115:500-3. https://doi.org/10.1542/peds.2004-1921
Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee 9Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448-53. https://doi.org/10.1161/01.CIR.0000060923.07573.F2
Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care. 2007;30:2588â€“92. https://doi.org/10.2337/dc07-0275
Marcovecchio LM, Mohn A, Chiarelli F. Obesity and insulin resistance in children. J Pediatr Gastroenterol Nutr. 2010;51:149-50. https://doi.org/10.1097/MPG.0b013e3181f853f9
Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciarldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New Engl J Med. 2006;354:2552-63. https://doi.org/10.1056/NEJMoa054862
Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab. 2007:92:4359â€“65. https://doi.org/10.1210/jc.2007-0468
Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93:2287-93. https://doi.org/10.1210/jc.2007-2745
Kanaka-Gantenbein C, Margeli A, Pervanidou P, Sakka S, Mastorakos G, Chrousos GP et al. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults". Clini Chem. 2008;54:1176-82. https://doi.org/10.1373/clinchem.2007.099002
Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, et al. Retinol-binding protein 4 in human obesity. Diabetes. 2006;55:2805-10. https://doi.org/10.2337/db06-0616
Tanumihardjo SA. Biomarkers of vitamin A status: what do they mean? In: World Health Organization. Report: Priorities in the assessment of vitamin A and iron status in populations; 2010 September 15â€“17; Panama City, Panama. Geneva: World Health Organization; 2012.
Fernandez-Real, JM, Moreno JM, Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistanceâ€“associated iron overload. Diabetes. 2008;57:1918-25. https://doi.org/10.2337/db08-0041
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.